John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,000 shares at $31.51 ($313K) on 2016-10-03, disclosed to the SEC on 2016-10-05.
Scheduled sale ($313k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.00 | 3,751 | $116K | 37.1% |
| 2 | $31.51 | 6,249 | $197K | 62.9% |
| Total | $31.32 avg | 10,000 | $313K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |